NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress response. Several nucleolar proteins stabilize p53 by interfering Mdm2–p53 interaction upon cellular stress, while other mechanisms by which n...
Saved in:
Published in | EMBO reports Vol. 17; no. 3; pp. 349 - 366 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Blackwell Publishing Ltd
01.03.2016
Nature Publishing Group UK Springer Nature B.V John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress response. Several nucleolar proteins stabilize p53 by interfering Mdm2–p53 interaction upon cellular stress, while other mechanisms by which nucleolar proteins activate p53 remain to be determined. Here, we identify NAT10 as a novel regulator for p53 activation. NAT10 acetylates p53 at K120 and stabilizes p53 by counteracting Mdm2 action. In addition, NAT10 promotes Mdm2 degradation with its intrinsic E3 ligase activity. After DNA damage, NAT10 translocates to nucleoplasm and activates p53‐mediated cell cycle control and apoptosis. Finally, NAT10 inhibits cell proliferation and expression of NAT10 decreases in human colorectal carcinomas. Thus, our data demonstrate that NAT10 plays a critical role in p53 activation via acetylating p53 and counteracting Mdm2 action, providing a novel pathway by which nucleolar protein activates p53 as a cellular stress sensor.
Synopsis
NAT10 acts as an E3 ligase for Mdm2 to promote Mdm2 degradation and stabilizes p53 under normal conditions. While under DNA damage conditions, NAT10 prevents Mdm2–p53 interaction by binding to p53 and acetylates p53, thus regulating p53‐mediated cell cycle arrest and apoptosis.
NAT10 promotes Mdm2 ubiquitination and degradation with its E3 ligase activity under normal conditions.
NAT10 acetylates p53 at K120.
NAT10 translocates to nucleoplasm to bind and acetylate p53 at K120 upon cellular stress, thus contributing to p53 activation.
Graphical Abstract
NAT10 acts as an E3 ligase for Mdm2 to promote Mdm2 degradation and stabilizes p53 under normal conditions. While under DNA damage conditions, NAT10 prevents Mdm2–p53 interaction by binding to p53 and acetylates p53, thus regulating p53‐mediated cell cycle arrest and apoptosis. |
---|---|
AbstractList | As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress response. Several nucleolar proteins stabilize p53 by interfering Mdm2–p53 interaction upon cellular stress, while other mechanisms by which nucleolar proteins activate p53 remain to be determined. Here, we identify
NAT
10 as a novel regulator for p53 activation.
NAT
10 acetylates p53 at K120 and stabilizes p53 by counteracting Mdm2 action. In addition,
NAT
10 promotes Mdm2 degradation with its intrinsic E3 ligase activity. After
DNA
damage,
NAT
10 translocates to nucleoplasm and activates p53‐mediated cell cycle control and apoptosis. Finally,
NAT
10 inhibits cell proliferation and expression of
NAT
10 decreases in human colorectal carcinomas. Thus, our data demonstrate that
NAT
10 plays a critical role in p53 activation via acetylating p53 and counteracting Mdm2 action, providing a novel pathway by which nucleolar protein activates p53 as a cellular stress sensor. As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress response. Several nucleolar proteins stabilize p53 by interfering Mdm2-p53 interaction upon cellular stress, while other mechanisms by which nucleolar proteins activate p53 remain to be determined. Here, we identify NAT10 as a novel regulator for p53 activation. NAT10 acetylates p53 at K120 and stabilizes p53 by counteracting Mdm2 action. In addition, NAT10 promotes Mdm2 degradation with its intrinsic E3 ligase activity. After DNA damage, NAT10 translocates to nucleoplasm and activates p53-mediated cell cycle control and apoptosis. Finally, NAT10 inhibits cell proliferation and expression of NAT10 decreases in human colorectal carcinomas. Thus, our data demonstrate that NAT10 plays a critical role in p53 activation via acetylating p53 and counteracting Mdm2 action, providing a novel pathway by which nucleolar protein activates p53 as a cellular stress sensor. As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress response. Several nucleolar proteins stabilize p53 by interfering Mdm2–p53 interaction upon cellular stress, while other mechanisms by which nucleolar proteins activate p53 remain to be determined. Here, we identify NAT10 as a novel regulator for p53 activation. NAT10 acetylates p53 at K120 and stabilizes p53 by counteracting Mdm2 action. In addition, NAT10 promotes Mdm2 degradation with its intrinsic E3 ligase activity. After DNA damage, NAT10 translocates to nucleoplasm and activates p53‐mediated cell cycle control and apoptosis. Finally, NAT10 inhibits cell proliferation and expression of NAT10 decreases in human colorectal carcinomas. Thus, our data demonstrate that NAT10 plays a critical role in p53 activation via acetylating p53 and counteracting Mdm2 action, providing a novel pathway by which nucleolar protein activates p53 as a cellular stress sensor. Synopsis NAT10 acts as an E3 ligase for Mdm2 to promote Mdm2 degradation and stabilizes p53 under normal conditions. While under DNA damage conditions, NAT10 prevents Mdm2–p53 interaction by binding to p53 and acetylates p53, thus regulating p53‐mediated cell cycle arrest and apoptosis. NAT10 promotes Mdm2 ubiquitination and degradation with its E3 ligase activity under normal conditions. NAT10 acetylates p53 at K120. NAT10 translocates to nucleoplasm to bind and acetylate p53 at K120 upon cellular stress, thus contributing to p53 activation. Graphical Abstract NAT10 acts as an E3 ligase for Mdm2 to promote Mdm2 degradation and stabilizes p53 under normal conditions. While under DNA damage conditions, NAT10 prevents Mdm2–p53 interaction by binding to p53 and acetylates p53, thus regulating p53‐mediated cell cycle arrest and apoptosis. As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress response. Several nucleolar proteins stabilize p53 by interfering Mdm2-p53 interaction upon cellular stress, while other mechanisms by which nucleolar proteins activate p53 remain to be determined. Here, we identify NAT10 as a novel regulator for p53 activation. NAT10 acetylates p53 at K120 and stabilizes p53 by counteracting Mdm2 action. In addition, NAT10 promotes Mdm2 degradation with its intrinsic E3 ligase activity. After DNA damage, NAT10 translocates to nucleoplasm and activates p53-mediated cell cycle control and apoptosis. Finally, NAT10 inhibits cell proliferation and expression of NAT10 decreases in human colorectal carcinomas. Thus, our data demonstrate that NAT10 plays a critical role in p53 activation via acetylating p53 and counteracting Mdm2 action, providing a novel pathway by which nucleolar protein activates p53 as a cellular stress sensor.As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress response. Several nucleolar proteins stabilize p53 by interfering Mdm2-p53 interaction upon cellular stress, while other mechanisms by which nucleolar proteins activate p53 remain to be determined. Here, we identify NAT10 as a novel regulator for p53 activation. NAT10 acetylates p53 at K120 and stabilizes p53 by counteracting Mdm2 action. In addition, NAT10 promotes Mdm2 degradation with its intrinsic E3 ligase activity. After DNA damage, NAT10 translocates to nucleoplasm and activates p53-mediated cell cycle control and apoptosis. Finally, NAT10 inhibits cell proliferation and expression of NAT10 decreases in human colorectal carcinomas. Thus, our data demonstrate that NAT10 plays a critical role in p53 activation via acetylating p53 and counteracting Mdm2 action, providing a novel pathway by which nucleolar protein activates p53 as a cellular stress sensor. As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress response. Several nucleolar proteins stabilize p53 by interfering Mdm2–p53 interaction upon cellular stress, while other mechanisms by which nucleolar proteins activate p53 remain to be determined. Here, we identify NAT10 as a novel regulator for p53 activation. NAT10 acetylates p53 at K120 and stabilizes p53 by counteracting Mdm2 action. In addition, NAT10 promotes Mdm2 degradation with its intrinsic E3 ligase activity. After DNA damage, NAT10 translocates to nucleoplasm and activates p53‐mediated cell cycle control and apoptosis. Finally, NAT10 inhibits cell proliferation and expression of NAT10 decreases in human colorectal carcinomas. Thus, our data demonstrate that NAT10 plays a critical role in p53 activation via acetylating p53 and counteracting Mdm2 action, providing a novel pathway by which nucleolar protein activates p53 as a cellular stress sensor. Synopsis NAT10 acts as an E3 ligase for Mdm2 to promote Mdm2 degradation and stabilizes p53 under normal conditions. While under DNA damage conditions, NAT10 prevents Mdm2–p53 interaction by binding to p53 and acetylates p53, thus regulating p53‐mediated cell cycle arrest and apoptosis. NAT10 promotes Mdm2 ubiquitination and degradation with its E3 ligase activity under normal conditions. NAT10 acetylates p53 at K120. NAT10 translocates to nucleoplasm to bind and acetylate p53 at K120 upon cellular stress, thus contributing to p53 activation. NAT10 acts as an E3 ligase for Mdm2 to promote Mdm2 degradation and stabilizes p53 under normal conditions. While under DNA damage conditions, NAT10 prevents Mdm2–p53 interaction by binding to p53 and acetylates p53, thus regulating p53‐mediated cell cycle arrest and apoptosis. As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress response. Several nucleolar proteins stabilize p53 by interfering Mdm2-p53 interaction upon cellular stress, while other mechanisms by which nucleolar proteins activate p53 remain to be determined. Here, we identify NAT10 as a novel regulator for p53 activation. NAT10 acetylates p53 at K120 and stabilizes p53 by counteracting Mdm2 action. In addition, NAT10 promotes Mdm2 degradation with its intrinsic E3 ligase activity. After DNA damage, NAT10 translocates to nucleoplasm and activates p53-mediated cell cycle control and apoptosis. Finally, NAT10 inhibits cell proliferation and expression of NAT10 decreases in human colorectal carcinomas. Thus, our data demonstrate that NAT10 plays a critical role in p53 activation via acetylating p53 and counteracting Mdm2 action, providing a novel pathway by which nucleolar protein activates p53 as a cellular stress sensor. Synopsis NAT10 acts as an E3 ligase for Mdm2 to promote Mdm2 degradation and stabilizes p53 under normal conditions. While under DNA damage conditions, NAT10 prevents Mdm2-p53 interaction by binding to p53 and acetylates p53, thus regulating p53-mediated cell cycle arrest and apoptosis. NAT10 promotes Mdm2 ubiquitination and degradation with its E3 ligase activity under normal conditions. NAT10 acetylates p53 at K120. NAT10 translocates to nucleoplasm to bind and acetylate p53 at K120 upon cellular stress, thus contributing to p53 activation. |
Author | Luo, Jianyuan Ke, Yang Du, Xiaojuan Zhang, Chunfeng Zhang, Liangliang Deng, Hongkui Tan, Yuqin Zhang, Ying Ren, Pengwei Liu, Xiaofeng |
AuthorAffiliation | 1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Health Science Center Beijing China 2 Department of Cell Biology School of Basic Medical Sciences Peking University Health Science Center Beijing China 5 Department of Medical & Research Technology School of Medicine University of Maryland Baltimore MD USA 4 Laboratory of Genetics Peking University School of Oncology Peking University Cancer Hospital & Institute Beijing China 3 Department of Medical Genetics School of Basic Medical Sciences Peking University Health Science Center Beijing China |
AuthorAffiliation_xml | – name: 2 Department of Cell Biology School of Basic Medical Sciences Peking University Health Science Center Beijing China – name: 3 Department of Medical Genetics School of Basic Medical Sciences Peking University Health Science Center Beijing China – name: 1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Health Science Center Beijing China – name: 4 Laboratory of Genetics Peking University School of Oncology Peking University Cancer Hospital & Institute Beijing China – name: 5 Department of Medical & Research Technology School of Medicine University of Maryland Baltimore MD USA |
Author_xml | – sequence: 1 givenname: Xiaofeng surname: Liu fullname: Liu, Xiaofeng organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China – sequence: 2 givenname: Yuqin surname: Tan fullname: Tan, Yuqin organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China – sequence: 3 givenname: Chunfeng surname: Zhang fullname: Zhang, Chunfeng organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China – sequence: 4 givenname: Ying surname: Zhang fullname: Zhang, Ying organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China – sequence: 5 givenname: Liangliang surname: Zhang fullname: Zhang, Liangliang organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China – sequence: 6 givenname: Pengwei surname: Ren fullname: Ren, Pengwei organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China – sequence: 7 givenname: Hongkui surname: Deng fullname: Deng, Hongkui organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China – sequence: 8 givenname: Jianyuan surname: Luo fullname: Luo, Jianyuan organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China – sequence: 9 givenname: Yang surname: Ke fullname: Ke, Yang organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China – sequence: 10 givenname: Xiaojuan surname: Du fullname: Du, Xiaojuan email: duxiaojuan100@bjmu.edu.cn organization: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26882543$$D View this record in MEDLINE/PubMed |
BookMark | eNptkc1v1DAQxS1URD_gzA1F4sIlxXZij80BqVRtQW0XCRaKuFjeZDbrkjhbJynsf4_bLFFBnPzxfu95PLNPdnzrkZDnjB4ywQV_jc0iHHLKRE4FFY_IHsulTjMGame755x92yX7XXdNKRUa1BOyy6VSXOTZHvk6O5ozmgSshtr22CVrkSW26N2t7V3rk34V2qFaxSvsN5FwvhqRPjlnnCbWl8mwcDeDi9IoX5YNf0oeL23d4bPtekC-nJ7Mj9-nFx_PPhwfXaROSCpSxgGZtUAp1zxDAZrhApQty0ICowq4ZDovtNW0xLzgXOllvqSAEjPMAbMD8nbMXQ-LBssCfR9sbdbBNTZsTGud-VvxbmWq9tbkAFyDjAGvtgGhvRmw603jugLr2npsh84wABo7KKSK6Mt_0Ot2CD5-L1JSaQqK3VEvHlY0lfKn5RF4MwI_XY2bSWfU3E_U3E3UTBM1J5fvPk2naKajuYs-X2F4UMP_A6IlHS2u6_HX9J4NP4yEDIS5mp0ZfjU7_Qzf50ZkvwHIjLNz |
CODEN | ERMEAX |
ContentType | Journal Article |
Copyright | The Authors. Published under the terms of the CC BY NC ND 4.0 license 2016 2016 The Authors. Published under the terms of the CC BY NC ND 4.0 license 2016 The Authors. Published under the terms of the CC BY NC ND 4.0 license. 2016 EMBO |
Copyright_xml | – notice: The Authors. Published under the terms of the CC BY NC ND 4.0 license 2016 – notice: 2016 The Authors. Published under the terms of the CC BY NC ND 4.0 license – notice: 2016 The Authors. Published under the terms of the CC BY NC ND 4.0 license. – notice: 2016 EMBO |
DBID | BSCLL C6C 24P CGR CUY CVF ECM EIF NPM 7QL 7T5 7TM 7TO 7U9 8FD C1K FR3 H94 K9. M7N P64 RC3 7X8 5PM |
DOI | 10.15252/embr.201540505 |
DatabaseName | Istex Springer Nature OA Free Journals Wiley Online Library Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Genetics Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
DocumentTitleAlternate | Xiaofeng Liu et al |
EISSN | 1469-3178 |
EndPage | 366 |
ExternalDocumentID | PMC4772976 3967394151 26882543 EMBR201540505 10_15252_embr_201540505 ark_67375_WNG_2WNFS7ZT_5 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Innovation Team of Ministry of Education grantid: IRT13001 – fundername: 973 Program grantid: 2010CB529303 – fundername: National Natural Science Foundation of China grantid: 81171877; 81371868; 81321003 funderid: 10.13039/501100001809 – fundername: National Natural Science Foundation of China funderid: 81171877; 81371868; 81321003 – fundername: 973 Program funderid: 2010CB529303 – fundername: Innovation Team of Ministry of Education funderid: IRT13001 – fundername: National Natural Science Foundation of China grantid: 81171877; 81371868; 81321003 |
GroupedDBID | --- -DZ -Q- .55 0R~ 1OC 24P 29G 2WC 33P 36B 39C 3O- 3V. 53G 5GY 5VS 70F 7X7 88A 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AAESR AAEVG AAHBH AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCUV ABJNI ABLJU ABUWG ABZEH ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACNCT ACPOU ACPRK ACSMW ACXBN ACXQS ADBBV ADEOM ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AENEX AEQDE AEUYR AFBPY AFGKR AFKRA AFPWT AFRAH AFZJQ AHMBA AIAGR AIURR AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOIJS ASPBG AUFTA AVWKF AZBYB AZFZN AZQEC AZVAB BAWUL BBNVY BDRZF BENPR BFHJK BHPHI BMNLL BMXJE BPHCQ BRXPI BSCLL BTFSW BVXVI C1A C6C CAG CCPQU COF CS3 DCZOG DIK DPXWK DRFUL DRSTM DWQXO E3Z EBLON EBS EJD EMB EMOBN F5P FEDTE FYUFA G-S GNUQQ GODZA GROUPED_DOAJ GUQSH GX1 H13 HCIFZ HK~ HMCUK HVGLF HYE H~9 KQ8 L7B LATKE LEEKS LH4 LITHE LK8 LOXES LUTES LW6 LYRES M0L M1P M2O M7P MEWTI MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM MY~ O9- OK1 P2P P2W PQQKQ PROAC PSQYO Q2X R.K RHF RHI RIG RNI RNS ROL RPM RZO SV3 TR2 UKHRP WBKPD WIH WIK WIN WOHZO WOQ WXSBR WYJ X7M ZGI ZZTAW AAJSJ AAYCA AFWVQ AANHP ACRPL ACYXJ ADNMO AEUYN AAMMB AASML AEFGJ AGQPQ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NAO NPM PHGZM PHGZT PJZUB PPXIY PQGLB 7QL 7T5 7TM 7TO 7U9 8FD C1K FR3 H94 K9. M7N P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-i5605-127e1aa7002923e5791eb78addc67108726194c9a90de4c2289f4f07e6e3e47e3 |
IEDL.DBID | C6C |
ISSN | 1469-221X 1469-3178 |
IngestDate | Thu Aug 21 18:28:54 EDT 2025 Fri Jul 11 07:50:23 EDT 2025 Fri Jul 25 11:00:02 EDT 2025 Mon Jul 21 06:03:51 EDT 2025 Wed Jan 22 16:34:51 EST 2025 Fri Feb 21 02:36:37 EST 2025 Wed Oct 30 09:51:49 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | acetylation Mdm2 NAT10 E3 ligase p53 |
Language | English |
License | Attribution-NonCommercial-NoDerivs 2016 The Authors. Published under the terms of the CC BY NC ND 4.0 license. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-i5605-127e1aa7002923e5791eb78addc67108726194c9a90de4c2289f4f07e6e3e47e3 |
Notes | Innovation Team of Ministry of Education - No. IRT13001 973 Program - No. 2010CB529303 National Natural Science Foundation of China - No. 81171877; No. 81371868; No. 81321003 ark:/67375/WNG-2WNFS7ZT-5 ArticleID:EMBR201540505 Expanded View Figures PDFReview Process FileSource Data for Figure 6C istex:5FB60E86E80F9DF827C5C8A58657CD87A8162AE6 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doi.org/10.15252/embr.201540505 |
PMID | 26882543 |
PQID | 1768907818 |
PQPubID | 26169 |
PageCount | 18 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4772976 proquest_miscellaneous_1770221568 proquest_journals_1768907818 pubmed_primary_26882543 wiley_primary_10_15252_embr_201540505_EMBR201540505 springer_journals_10_15252_embr_201540505 istex_primary_ark_67375_WNG_2WNFS7ZT_5 |
PublicationCentury | 2000 |
PublicationDate | March 2016 |
PublicationDateYYYYMMDD | 2016-03-01 |
PublicationDate_xml | – month: 03 year: 2016 text: March 2016 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England – name: New York – name: Hoboken |
PublicationTitle | EMBO reports |
PublicationTitleAbbrev | EMBO Rep |
PublicationTitleAlternate | EMBO rep |
PublicationYear | 2016 |
Publisher | Blackwell Publishing Ltd Nature Publishing Group UK Springer Nature B.V John Wiley and Sons Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Nature Publishing Group UK – name: Springer Nature B.V – name: John Wiley and Sons Inc |
References | Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, Baer R, Gu W (2012) Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 149: 1269-1283 Hussain SP, Harris CC (1999) p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutat Res 428: 23-32 Brooks CL, Gu W (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-171 Meng L, Lin T, Tsai RY (2008) Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival. J Cell Sci 121: 4037-4046 Rokudai S, Laptenko O, Arnal SM, Taya Y, Kitabayashi I, Prives C (2013) MOZ increases p53 acetylation and premature senescence through its complex formation with PML. Proc Natl Acad Sci USA 110: 3895-3900 Yuan J, Luo K, Zhang L, Cheville JC, Lou Z (2010) USP10 regulates p53 localization and stability by deubiquitinating p53. Cell 140: 384-396 Lee S, Kim JY, Kim YJ, Seok KO, Kim JH, Chang YJ, Kang HY, Park JH (2012) Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses. Cell Death Differ 19: 1613-1622 Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148 Forslund A, Zeng Z, Qin LX, Rosenberg S, Ndubuisi M, Pincas H, Gerald W, Notterman DA, Barany F, Paty PB (2008) MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers. Mol Cancer Res 6: 205-211 Luo J, Su F, Chen D, Shiloh A, Gu W (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377-381 Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303 el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825 Thut CJ, Goodrich JA, Tjian R (1997) Repression of p53-mediated transcription by MDM2: a dual mechanism. Genes Dev 11: 1974-1986 Lu L, Berkey KA, Casero RA Jr (1996) RGFGIGS is an amino acid sequence required for acetyl coenzyme A binding and activity of human spermidine/spermine N1acetyltransferase. J Biol Chem 271: 18920-18924 Inuzuka H, Tseng A, Gao D, Zhai B, Zhang Q, Shaik S, Wan L, Ang XL, Mock C, Yin H et al (2010) Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase. Cancer Cell 18: 147-159 Kubbutat MH, Ludwig RL, Levine AJ, Vousden KH (1999) Analysis of the degradation function of Mdm2. Cell Growth Differ 10: 87-92 Shibagaki I, Tanaka H, Shimada Y, Wagata T, Ikenaga M, Imamura M, Ishizaki K (1995) p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Clin Cancer Res 1: 769-773 Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408: 307-310 Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H (2004) Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 24: 7654-7668 Larrieu D, Britton S, Demir M, Rodriguez R, Jackson SP (2014) Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science 344: 527-532 Li M, Luo J, Brooks CL, Gu W (2002) Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277: 50607-50611 Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D (1999) Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1: 20-26 Honda R, Yasuda H (1999) Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 18: 22-27 Honda R, Yasuda H (2000) Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 19: 1473-1476 Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, Xiong Y (2003) Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 23: 8902-8912 Lv J, Liu H, Wang Q, Tang Z, Hou L, Zhang B (2003) Molecular cloning of a novel human gene encoding histone acetyltransferase-like protein involved in transcriptional activation of hTERT. Biochem Biophys Res Commun 311: 506-513 Xu C, Fan CD, Wang X (2015) Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase. Oncogene 34: 281-289 Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH (2003) Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3: 577-587 Zhang Y, Lu H (2009) Signaling to p53: ribosomal proteins find their way. Cancer Cell 16: 369-377 Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, Weissman AM (1999) RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci USA 96: 11364-11369 Shen Q, Zheng X, McNutt MA, Guang L, Sun Y, Wang J, Gong Y, Hou L, Zhang B (2009) NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules. Exp Cell Res 315: 1653-1667 Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS, McMahon SB (2006) Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 24: 841-851 Jones SN, Roe AE, Donehower LA, Bradley A (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208 Zhang Y, Xiong Y, Yarbrough WG (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725-734 Krummel KA, Lee CJ, Toledo F, Wahl GM (2005) The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc Natl Acad Sci USA 102: 10188-10193 Vousden KH, Lu X (2002) Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604 Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W (2004) Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci USA 101: 2259-2264 Brooks CL, Gu W (2010) New insights into p53 activation. Cell Res 20: 614-621 Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM (2000) Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275: 8945-8951 Riley T, Sontag E, Chen P, Levine A (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412 Tang Y, Luo J, Zhang W, Gu W (2006) Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 24: 827-839 Metzger MB, Hristova VA, Weissman AM (2012) HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci 125: 531-537 Rubbi CP, Milner J (2003) Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J 22: 6068-6077 Kurki S, Peltonen K, Latonen L, Kiviharju TM, Ojala PM, Meek D, Laiho M (2004) Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5: 465-475 Dai MS, Lu H (2004) Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 279: 44475-44482 Itahana K, Mao H, Jin A, Itahana Y, Clegg HV, Lindstrom MS, Bhat KP, Godfrey VL, Evan GI, Zhang Y (2007) Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell 12: 355-366 Momand J, Jung D, Wilczynski S, Niland J (1998) The MDM2 gene amplification database. Nucleic Acids Res 26: 3453-3459 Tao W, Levine AJ (1999) P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc Natl Acad Sci USA 96: 6937-6941 Montes de Oca Luna R, Wagner DS, Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206 Honda R, Tanaka H, Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420: 25-27 Brooks CL, Gu W (2006) p53 ubiquitination: Mdm2 and beyond. Mol Cell 21: 307-315 Tang Y, Zhao W, Chen Y, Zhao Y, Gu W (2008) Acetylation is indispensable for p53 activation. Cell 133: 612-626 Berndsen CE, Wolberger C (2014) New insights into ubiquitin E3 ligase mechanism. Nat Struct Mol Biol 21: 301-307 Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 137: 413-431 Kong R, Zhang L, Hu L, Peng Q, Han W, Du X, Ke Y (2011) hALP, a novel transcriptional U three protein (t-UTP), activates RNA polymerase I transcription by binding and acetylating the upstream binding factor (UBF). J Biol Chem 286: 7139-7148 Jin A, Itahana K, O'Keefe K, Zhang Y (2004) Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 24: 7669-7680 Sherr CJ (2006) Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6: 663-673 Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606 Linares LK, Kiernan R, Triboulet R, Chable-Bessia C, Latreille D, Cuvier O, Lacroix M, Le Cam L, Coux O, Benkirane M (2007) Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol 9: 331-338 Jones, Roe, Donehower, Bradley (CR8) 1995; 378 Tang, Luo, Zhang, Gu (CR28) 2006; 24 Meng, Lin, Tsai (CR48) 2008; 121 Inuzuka, Tseng, Gao, Zhai, Zhang, Shaik, Wan, Ang, Mock, Yin (CR53) 2010; 18 Xu, Fan, Wang (CR54) 2015; 34 Shen, Zheng, McNutt, Guang, Sun, Wang, Gong, Hou, Zhang (CR35) 2009; 315 Shibagaki, Tanaka, Shimada, Wagata, Ikenaga, Imamura, Ishizaki (CR13) 1995; 1 Sykes, Mellert, Holbert, Li, Marmorstein, Lane, McMahon (CR29) 2006; 24 Krummel, Lee, Toledo, Wahl (CR27) 2005; 102 Luo, Li, Tang, Laszkowska, Roeder, Gu (CR26) 2004; 101 Kurki, Peltonen, Latonen, Kiviharju, Ojala, Meek, Laiho (CR47) 2004; 5 Weber, Taylor, Roussel, Sherr, Bar‐Sagi (CR44) 1999; 1 Riley, Sontag, Chen, Levine (CR4) 2008; 9 Honda, Yasuda (CR16) 1999; 18 Yuan, Luo, Zhang, Cheville, Lou (CR59) 2010; 140 Momand, Jung, Wilczynski, Niland (CR11) 1998; 26 Vousden, Lu (CR3) 2002; 2 Gu, Roeder (CR23) 1997; 90 Vousden, Prives (CR43) 2009; 137 Vogelstein, Lane, Levine (CR2) 2000; 408 Thut, Goodrich, Tjian (CR9) 1997; 11 Dai, Lu (CR18) 2004; 279 Kubbutat, Ludwig, Levine, Vousden (CR41) 1999; 10 Sherr (CR22) 2006; 6 Jin, Itahana, O'Keefe, Zhang (CR46) 2004; 24 el‐Deiry, Tokino, Velculescu, Levy, Parsons, Trent, Lin, Mercer, Kinzler, Vogelstein (CR58) 1993; 75 Metzger, Hristova, Weissman (CR55) 2012; 125 Brooks, Gu (CR21) 2010; 20 Zhang, Xiong, Yarbrough (CR17) 1998; 92 Luo, Su, Chen, Shiloh, Gu (CR24) 2000; 408 Lohrum, Ludwig, Kubbutat, Hanlon, Vousden (CR45) 2003; 3 Lorick, Jensen, Fang, Ong, Hatakeyama, Weissman (CR42) 1999; 96 Honda, Yasuda (CR40) 2000; 19 Itahana, Mao, Jin, Itahana, Clegg, Lindstrom, Bhat, Godfrey, Evan, Zhang (CR51) 2007; 12 Forslund, Zeng, Qin, Rosenberg, Ndubuisi, Pincas, Gerald, Notterman, Barany, Paty (CR12) 2008; 6 Fang, Jensen, Ludwig, Vousden, Weissman (CR39) 2000; 275 Honda, Tanaka, Yasuda (CR6) 1997; 420 Lv, Liu, Wang, Tang, Hou, Zhang (CR32) 2003; 311 Brooks, Gu (CR14) 2006; 21 Dai, Zeng, Jin, Sun, David, Lu (CR20) 2004; 24 Kubbutat, Jones, Vousden (CR10) 1997; 387 Luo, Nikolaev, Imai, Chen, Su, Shiloh, Guarente, Gu (CR25) 2001; 107 Hussain, Harris (CR1) 1999; 428 Brooks, Gu (CR5) 2003; 15 Linares, Kiernan, Triboulet, Chable‐Bessia, Latreille, Cuvier, Lacroix, Le Cam, Coux, Benkirane (CR52) 2007; 9 Zhang, Wolf, Bhat, Jin, Allio, Burkhart, Xiong (CR19) 2003; 23 Berndsen, Wolberger (CR56) 2014; 21 Larrieu, Britton, Demir, Rodriguez, Jackson (CR34) 2014; 344 Li, Kon, Jiang, Tan, Ludwig, Zhao, Baer, Gu (CR31) 2012; 149 Tao, Levine (CR57) 1999; 96 Li, Luo, Brooks, Gu (CR38) 2002; 277 Lee, Kim, Kim, Seok, Kim, Chang, Kang, Park (CR49) 2012; 19 Rubbi, Milner (CR50) 2003; 22 Kong, Zhang, Hu, Peng, Han, Du, Ke (CR33) 2011; 286 Rokudai, Laptenko, Arnal, Taya, Kitabayashi, Prives (CR30) 2013; 110 Zhang, Lu (CR15) 2009; 16 Tang, Zhao, Chen, Zhao, Gu (CR36) 2008; 133 Lu, Berkey, Casero (CR37) 1996; 271 Montes de Oca Luna, Wagner, Lozano (CR7) 1995; 378 2015; 34 2010; 18 2004; 24 2002; 277 2008; 9 2003; 15 2004; 5 2012; 19 1995; 378 2008; 6 2010; 140 2012; 125 2001; 107 2003; 311 2014; 21 2009; 315 2000; 408 1997; 90 2010; 20 2000; 19 1997; 11 2006; 24 2006; 21 1999; 18 2005; 102 1993; 75 1997; 420 1997; 387 2003; 3 2007; 9 1999; 10 1998; 92 1999; 96 2013; 110 2009; 16 2011; 286 2004; 101 1998; 26 2002; 2 2006; 6 2000; 275 1999; 1 1995; 1 2012; 149 2008; 121 2007; 12 2009; 137 1999; 428 2004; 279 1996; 271 2008; 133 2003; 22 2003; 23 2014; 344 |
References_xml | – reference: Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408: 307-310 – reference: Shibagaki I, Tanaka H, Shimada Y, Wagata T, Ikenaga M, Imamura M, Ishizaki K (1995) p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Clin Cancer Res 1: 769-773 – reference: Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148 – reference: Riley T, Sontag E, Chen P, Levine A (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412 – reference: Lu L, Berkey KA, Casero RA Jr (1996) RGFGIGS is an amino acid sequence required for acetyl coenzyme A binding and activity of human spermidine/spermine N1acetyltransferase. J Biol Chem 271: 18920-18924 – reference: Meng L, Lin T, Tsai RY (2008) Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival. J Cell Sci 121: 4037-4046 – reference: Rubbi CP, Milner J (2003) Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J 22: 6068-6077 – reference: Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W (2004) Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci USA 101: 2259-2264 – reference: Rokudai S, Laptenko O, Arnal SM, Taya Y, Kitabayashi I, Prives C (2013) MOZ increases p53 acetylation and premature senescence through its complex formation with PML. Proc Natl Acad Sci USA 110: 3895-3900 – reference: Zhang Y, Xiong Y, Yarbrough WG (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725-734 – reference: Honda R, Tanaka H, Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420: 25-27 – reference: Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303 – reference: Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H (2004) Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 24: 7654-7668 – reference: Brooks CL, Gu W (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-171 – reference: Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, Baer R, Gu W (2012) Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 149: 1269-1283 – reference: Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, Weissman AM (1999) RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci USA 96: 11364-11369 – reference: Momand J, Jung D, Wilczynski S, Niland J (1998) The MDM2 gene amplification database. Nucleic Acids Res 26: 3453-3459 – reference: Yuan J, Luo K, Zhang L, Cheville JC, Lou Z (2010) USP10 regulates p53 localization and stability by deubiquitinating p53. Cell 140: 384-396 – reference: Jin A, Itahana K, O'Keefe K, Zhang Y (2004) Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 24: 7669-7680 – reference: Honda R, Yasuda H (1999) Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 18: 22-27 – reference: Forslund A, Zeng Z, Qin LX, Rosenberg S, Ndubuisi M, Pincas H, Gerald W, Notterman DA, Barany F, Paty PB (2008) MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers. Mol Cancer Res 6: 205-211 – reference: Metzger MB, Hristova VA, Weissman AM (2012) HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci 125: 531-537 – reference: Brooks CL, Gu W (2006) p53 ubiquitination: Mdm2 and beyond. Mol Cell 21: 307-315 – reference: Zhang Y, Lu H (2009) Signaling to p53: ribosomal proteins find their way. Cancer Cell 16: 369-377 – reference: Tao W, Levine AJ (1999) P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc Natl Acad Sci USA 96: 6937-6941 – reference: Kubbutat MH, Ludwig RL, Levine AJ, Vousden KH (1999) Analysis of the degradation function of Mdm2. Cell Growth Differ 10: 87-92 – reference: Larrieu D, Britton S, Demir M, Rodriguez R, Jackson SP (2014) Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science 344: 527-532 – reference: Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM (2000) Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275: 8945-8951 – reference: Thut CJ, Goodrich JA, Tjian R (1997) Repression of p53-mediated transcription by MDM2: a dual mechanism. Genes Dev 11: 1974-1986 – reference: Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 137: 413-431 – reference: Linares LK, Kiernan R, Triboulet R, Chable-Bessia C, Latreille D, Cuvier O, Lacroix M, Le Cam L, Coux O, Benkirane M (2007) Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol 9: 331-338 – reference: Vousden KH, Lu X (2002) Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604 – reference: Shen Q, Zheng X, McNutt MA, Guang L, Sun Y, Wang J, Gong Y, Hou L, Zhang B (2009) NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules. Exp Cell Res 315: 1653-1667 – reference: Berndsen CE, Wolberger C (2014) New insights into ubiquitin E3 ligase mechanism. Nat Struct Mol Biol 21: 301-307 – reference: Jones SN, Roe AE, Donehower LA, Bradley A (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208 – reference: Sherr CJ (2006) Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6: 663-673 – reference: Itahana K, Mao H, Jin A, Itahana Y, Clegg HV, Lindstrom MS, Bhat KP, Godfrey VL, Evan GI, Zhang Y (2007) Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell 12: 355-366 – reference: Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606 – reference: Lee S, Kim JY, Kim YJ, Seok KO, Kim JH, Chang YJ, Kang HY, Park JH (2012) Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses. Cell Death Differ 19: 1613-1622 – reference: Luo J, Su F, Chen D, Shiloh A, Gu W (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377-381 – reference: Dai MS, Lu H (2004) Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 279: 44475-44482 – reference: Inuzuka H, Tseng A, Gao D, Zhai B, Zhang Q, Shaik S, Wan L, Ang XL, Mock C, Yin H et al (2010) Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase. Cancer Cell 18: 147-159 – reference: Hussain SP, Harris CC (1999) p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutat Res 428: 23-32 – reference: Kurki S, Peltonen K, Latonen L, Kiviharju TM, Ojala PM, Meek D, Laiho M (2004) Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5: 465-475 – reference: Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, Xiong Y (2003) Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 23: 8902-8912 – reference: Brooks CL, Gu W (2010) New insights into p53 activation. Cell Res 20: 614-621 – reference: Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH (2003) Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3: 577-587 – reference: Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D (1999) Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1: 20-26 – reference: Tang Y, Luo J, Zhang W, Gu W (2006) Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 24: 827-839 – reference: Montes de Oca Luna R, Wagner DS, Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206 – reference: Xu C, Fan CD, Wang X (2015) Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase. Oncogene 34: 281-289 – reference: el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825 – reference: Lv J, Liu H, Wang Q, Tang Z, Hou L, Zhang B (2003) Molecular cloning of a novel human gene encoding histone acetyltransferase-like protein involved in transcriptional activation of hTERT. Biochem Biophys Res Commun 311: 506-513 – reference: Li M, Luo J, Brooks CL, Gu W (2002) Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277: 50607-50611 – reference: Honda R, Yasuda H (2000) Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 19: 1473-1476 – reference: Kong R, Zhang L, Hu L, Peng Q, Han W, Du X, Ke Y (2011) hALP, a novel transcriptional U three protein (t-UTP), activates RNA polymerase I transcription by binding and acetylating the upstream binding factor (UBF). J Biol Chem 286: 7139-7148 – reference: Tang Y, Zhao W, Chen Y, Zhao Y, Gu W (2008) Acetylation is indispensable for p53 activation. Cell 133: 612-626 – reference: Krummel KA, Lee CJ, Toledo F, Wahl GM (2005) The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc Natl Acad Sci USA 102: 10188-10193 – reference: Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS, McMahon SB (2006) Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 24: 841-851 – volume: 378 start-page: 206 year: 1995 end-page: 208 ident: CR8 article-title: Rescue of embryonic lethality in Mdm2‐deficient mice by absence of p53 publication-title: Nature – volume: 277 start-page: 50607 year: 2002 end-page: 50611 ident: CR38 article-title: Acetylation of p53 inhibits its ubiquitination by Mdm2 publication-title: J Biol Chem – volume: 279 start-page: 44475 year: 2004 end-page: 44482 ident: CR18 article-title: Inhibition of MDM2‐mediated p53 ubiquitination and degradation by ribosomal protein L5 publication-title: J Biol Chem – volume: 387 start-page: 299 year: 1997 end-page: 303 ident: CR10 article-title: Regulation of p53 stability by Mdm2 publication-title: Nature – volume: 271 start-page: 18920 year: 1996 end-page: 18924 ident: CR37 article-title: RGFGIGS is an amino acid sequence required for acetyl coenzyme A binding and activity of human spermidine/spermine N1acetyltransferase publication-title: J Biol Chem – volume: 107 start-page: 137 year: 2001 end-page: 148 ident: CR25 article-title: Negative control of p53 by Sir2alpha promotes cell survival under stress publication-title: Cell – volume: 34 start-page: 281 year: 2015 end-page: 289 ident: CR54 article-title: Regulation of Mdm2 protein stability and the p53 response by NEDD4‐1 E3 ligase publication-title: Oncogene – volume: 6 start-page: 205 year: 2008 end-page: 211 ident: CR12 article-title: MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers publication-title: Mol Cancer Res – volume: 10 start-page: 87 year: 1999 end-page: 92 ident: CR41 article-title: Analysis of the degradation function of Mdm2 publication-title: Cell Growth Differ – volume: 18 start-page: 147 year: 2010 end-page: 159 ident: CR53 article-title: Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta‐TRCP) ubiquitin ligase publication-title: Cancer Cell – volume: 275 start-page: 8945 year: 2000 end-page: 8951 ident: CR39 article-title: Mdm2 is a RING finger‐dependent ubiquitin protein ligase for itself and p53 publication-title: J Biol Chem – volume: 9 start-page: 331 year: 2007 end-page: 338 ident: CR52 article-title: Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2 publication-title: Nat Cell Biol – volume: 121 start-page: 4037 year: 2008 end-page: 4046 ident: CR48 article-title: Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2‐M progression and cell survival publication-title: J Cell Sci – volume: 428 start-page: 23 year: 1999 end-page: 32 ident: CR1 article-title: p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer publication-title: Mutat Res – volume: 21 start-page: 307 year: 2006 end-page: 315 ident: CR14 article-title: p53 ubiquitination: Mdm2 and beyond publication-title: Mol Cell – volume: 24 start-page: 841 year: 2006 end-page: 851 ident: CR29 article-title: Acetylation of the p53 DNA‐binding domain regulates apoptosis induction publication-title: Mol Cell – volume: 22 start-page: 6068 year: 2003 end-page: 6077 ident: CR50 article-title: Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses publication-title: EMBO J – volume: 311 start-page: 506 year: 2003 end-page: 513 ident: CR32 article-title: Molecular cloning of a novel human gene encoding histone acetyltransferase‐like protein involved in transcriptional activation of hTERT publication-title: Biochem Biophys Res Commun – volume: 18 start-page: 22 year: 1999 end-page: 27 ident: CR16 article-title: Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53 publication-title: EMBO J – volume: 26 start-page: 3453 year: 1998 end-page: 3459 ident: CR11 article-title: The MDM2 gene amplification database publication-title: Nucleic Acids Res – volume: 344 start-page: 527 year: 2014 end-page: 532 ident: CR34 article-title: Chemical inhibition of NAT10 corrects defects of laminopathic cells publication-title: Science – volume: 96 start-page: 6937 year: 1999 end-page: 6941 ident: CR57 article-title: P19(ARF) stabilizes p53 by blocking nucleo‐cytoplasmic shuttling of Mdm2 publication-title: Proc Natl Acad Sci USA – volume: 149 start-page: 1269 year: 2012 end-page: 1283 ident: CR31 article-title: Tumor suppression in the absence of p53‐mediated cell‐cycle arrest, apoptosis, and senescence publication-title: Cell – volume: 12 start-page: 355 year: 2007 end-page: 366 ident: CR51 article-title: Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation publication-title: Cancer Cell – volume: 315 start-page: 1653 year: 2009 end-page: 1667 ident: CR35 article-title: NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules publication-title: Exp Cell Res – volume: 140 start-page: 384 year: 2010 end-page: 396 ident: CR59 article-title: USP10 regulates p53 localization and stability by deubiquitinating p53 publication-title: Cell – volume: 75 start-page: 817 year: 1993 end-page: 825 ident: CR58 article-title: WAF1, a potential mediator of p53 tumor suppression publication-title: Cell – volume: 5 start-page: 465 year: 2004 end-page: 475 ident: CR47 article-title: Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2‐mediated degradation publication-title: Cancer Cell – volume: 19 start-page: 1473 year: 2000 end-page: 1476 ident: CR40 article-title: Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase publication-title: Oncogene – volume: 11 start-page: 1974 year: 1997 end-page: 1986 ident: CR9 article-title: Repression of p53‐mediated transcription by MDM2: a dual mechanism publication-title: Genes Dev – volume: 23 start-page: 8902 year: 2003 end-page: 8912 ident: CR19 article-title: Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53‐dependent ribosomal‐stress checkpoint pathway publication-title: Mol Cell Biol – volume: 102 start-page: 10188 year: 2005 end-page: 10193 ident: CR27 article-title: The C‐terminal lysines fine‐tune P53 stress responses in a mouse model but are not required for stability control or transactivation publication-title: Proc Natl Acad Sci USA – volume: 24 start-page: 7654 year: 2004 end-page: 7668 ident: CR20 article-title: Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition publication-title: Mol Cell Biol – volume: 286 start-page: 7139 year: 2011 end-page: 7148 ident: CR33 article-title: hALP, a novel transcriptional U three protein (t‐UTP), activates RNA polymerase I transcription by binding and acetylating the upstream binding factor (UBF) publication-title: J Biol Chem – volume: 125 start-page: 531 year: 2012 end-page: 537 ident: CR55 article-title: HECT and RING finger families of E3 ubiquitin ligases at a glance publication-title: J Cell Sci – volume: 19 start-page: 1613 year: 2012 end-page: 1622 ident: CR49 article-title: Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses publication-title: Cell Death Differ – volume: 378 start-page: 203 year: 1995 end-page: 206 ident: CR7 article-title: Rescue of early embryonic lethality in mdm2‐deficient mice by deletion of p53 publication-title: Nature – volume: 24 start-page: 827 year: 2006 end-page: 839 ident: CR28 article-title: Tip60‐dependent acetylation of p53 modulates the decision between cell‐cycle arrest and apoptosis publication-title: Mol Cell – volume: 24 start-page: 7669 year: 2004 end-page: 7680 ident: CR46 article-title: Inhibition of HDM2 and activation of p53 by ribosomal protein L23 publication-title: Mol Cell Biol – volume: 1 start-page: 20 year: 1999 end-page: 26 ident: CR44 article-title: Nucleolar Arf sequesters Mdm2 and activates p53 publication-title: Nat Cell Biol – volume: 133 start-page: 612 year: 2008 end-page: 626 ident: CR36 article-title: Acetylation is indispensable for p53 activation publication-title: Cell – volume: 9 start-page: 402 year: 2008 end-page: 412 ident: CR4 article-title: Transcriptional control of human p53‐regulated genes publication-title: Nat Rev Mol Cell Biol – volume: 16 start-page: 369 year: 2009 end-page: 377 ident: CR15 article-title: Signaling to p53: ribosomal proteins find their way publication-title: Cancer Cell – volume: 408 start-page: 377 year: 2000 end-page: 381 ident: CR24 article-title: Deacetylation of p53 modulates its effect on cell growth and apoptosis publication-title: Nature – volume: 92 start-page: 725 year: 1998 end-page: 734 ident: CR17 article-title: ARF promotes MDM2 degradation and stabilizes p53: ARF‐INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways publication-title: Cell – volume: 20 start-page: 614 year: 2010 end-page: 621 ident: CR21 article-title: New insights into p53 activation publication-title: Cell Res – volume: 96 start-page: 11364 year: 1999 end-page: 11369 ident: CR42 article-title: RING fingers mediate ubiquitin‐conjugating enzyme (E2)‐dependent ubiquitination publication-title: Proc Natl Acad Sci USA – volume: 137 start-page: 413 year: 2009 end-page: 431 ident: CR43 article-title: Blinded by the light: the growing complexity of p53 publication-title: Cell – volume: 110 start-page: 3895 year: 2013 end-page: 3900 ident: CR30 article-title: MOZ increases p53 acetylation and premature senescence through its complex formation with PML publication-title: Proc Natl Acad Sci USA – volume: 101 start-page: 2259 year: 2004 end-page: 2264 ident: CR26 article-title: Acetylation of p53 augments its site‐specific DNA binding both and publication-title: Proc Natl Acad Sci USA – volume: 15 start-page: 164 year: 2003 end-page: 171 ident: CR5 article-title: Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation publication-title: Curr Opin Cell Biol – volume: 420 start-page: 25 year: 1997 end-page: 27 ident: CR6 article-title: Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 publication-title: FEBS Lett – volume: 3 start-page: 577 year: 2003 end-page: 587 ident: CR45 article-title: Regulation of HDM2 activity by the ribosomal protein L11 publication-title: Cancer Cell – volume: 1 start-page: 769 year: 1995 end-page: 773 ident: CR13 article-title: p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma publication-title: Clin Cancer Res – volume: 21 start-page: 301 year: 2014 end-page: 307 ident: CR56 article-title: New insights into ubiquitin E3 ligase mechanism publication-title: Nat Struct Mol Biol – volume: 408 start-page: 307 year: 2000 end-page: 310 ident: CR2 article-title: Surfing the p53 network publication-title: Nature – volume: 2 start-page: 594 year: 2002 end-page: 604 ident: CR3 article-title: Live or let die: the cell's response to p53 publication-title: Nat Rev Cancer – volume: 90 start-page: 595 year: 1997 end-page: 606 ident: CR23 article-title: Activation of p53 sequence‐specific DNA binding by acetylation of the p53 C‐terminal domain publication-title: Cell – volume: 6 start-page: 663 year: 2006 end-page: 673 ident: CR22 article-title: Divorcing ARF and p53: an unsettled case publication-title: Nat Rev Cancer – volume: 20 start-page: 614 year: 2010 end-page: 621 article-title: New insights into p53 activation publication-title: Cell Res – volume: 315 start-page: 1653 year: 2009 end-page: 1667 article-title: NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules publication-title: Exp Cell Res – volume: 271 start-page: 18920 year: 1996 end-page: 18924 article-title: RGFGIGS is an amino acid sequence required for acetyl coenzyme A binding and activity of human spermidine/spermine N1acetyltransferase publication-title: J Biol Chem – volume: 277 start-page: 50607 year: 2002 end-page: 50611 article-title: Acetylation of p53 inhibits its ubiquitination by Mdm2 publication-title: J Biol Chem – volume: 21 start-page: 307 year: 2006 end-page: 315 article-title: p53 ubiquitination: Mdm2 and beyond publication-title: Mol Cell – volume: 121 start-page: 4037 year: 2008 end-page: 4046 article-title: Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2‐M progression and cell survival publication-title: J Cell Sci – volume: 133 start-page: 612 year: 2008 end-page: 626 article-title: Acetylation is indispensable for p53 activation publication-title: Cell – volume: 18 start-page: 22 year: 1999 end-page: 27 article-title: Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53 publication-title: EMBO J – volume: 26 start-page: 3453 year: 1998 end-page: 3459 article-title: The MDM2 gene amplification database publication-title: Nucleic Acids Res – volume: 18 start-page: 147 year: 2010 end-page: 159 article-title: Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta‐TRCP) ubiquitin ligase publication-title: Cancer Cell – volume: 15 start-page: 164 year: 2003 end-page: 171 article-title: Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation publication-title: Curr Opin Cell Biol – volume: 420 start-page: 25 year: 1997 end-page: 27 article-title: Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 publication-title: FEBS Lett – volume: 24 start-page: 841 year: 2006 end-page: 851 article-title: Acetylation of the p53 DNA‐binding domain regulates apoptosis induction publication-title: Mol Cell – volume: 311 start-page: 506 year: 2003 end-page: 513 article-title: Molecular cloning of a novel human gene encoding histone acetyltransferase‐like protein involved in transcriptional activation of hTERT publication-title: Biochem Biophys Res Commun – volume: 101 start-page: 2259 year: 2004 end-page: 2264 article-title: Acetylation of p53 augments its site‐specific DNA binding both and publication-title: Proc Natl Acad Sci USA – volume: 34 start-page: 281 year: 2015 end-page: 289 article-title: Regulation of Mdm2 protein stability and the p53 response by NEDD4‐1 E3 ligase publication-title: Oncogene – volume: 24 start-page: 827 year: 2006 end-page: 839 article-title: Tip60‐dependent acetylation of p53 modulates the decision between cell‐cycle arrest and apoptosis publication-title: Mol Cell – volume: 6 start-page: 205 year: 2008 end-page: 211 article-title: MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers publication-title: Mol Cancer Res – volume: 10 start-page: 87 year: 1999 end-page: 92 article-title: Analysis of the degradation function of Mdm2 publication-title: Cell Growth Differ – volume: 2 start-page: 594 year: 2002 end-page: 604 article-title: Live or let die: the cell's response to p53 publication-title: Nat Rev Cancer – volume: 344 start-page: 527 year: 2014 end-page: 532 article-title: Chemical inhibition of NAT10 corrects defects of laminopathic cells publication-title: Science – volume: 408 start-page: 377 year: 2000 end-page: 381 article-title: Deacetylation of p53 modulates its effect on cell growth and apoptosis publication-title: Nature – volume: 19 start-page: 1613 year: 2012 end-page: 1622 article-title: Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses publication-title: Cell Death Differ – volume: 387 start-page: 299 year: 1997 end-page: 303 article-title: Regulation of p53 stability by Mdm2 publication-title: Nature – volume: 96 start-page: 6937 year: 1999 end-page: 6941 article-title: P19(ARF) stabilizes p53 by blocking nucleo‐cytoplasmic shuttling of Mdm2 publication-title: Proc Natl Acad Sci USA – volume: 408 start-page: 307 year: 2000 end-page: 310 article-title: Surfing the p53 network publication-title: Nature – volume: 12 start-page: 355 year: 2007 end-page: 366 article-title: Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation publication-title: Cancer Cell – volume: 1 start-page: 20 year: 1999 end-page: 26 article-title: Nucleolar Arf sequesters Mdm2 and activates p53 publication-title: Nat Cell Biol – volume: 275 start-page: 8945 year: 2000 end-page: 8951 article-title: Mdm2 is a RING finger‐dependent ubiquitin protein ligase for itself and p53 publication-title: J Biol Chem – volume: 16 start-page: 369 year: 2009 end-page: 377 article-title: Signaling to p53: ribosomal proteins find their way publication-title: Cancer Cell – volume: 378 start-page: 203 year: 1995 end-page: 206 article-title: Rescue of early embryonic lethality in mdm2‐deficient mice by deletion of p53 publication-title: Nature – volume: 428 start-page: 23 year: 1999 end-page: 32 article-title: p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer publication-title: Mutat Res – volume: 6 start-page: 663 year: 2006 end-page: 673 article-title: Divorcing ARF and p53: an unsettled case publication-title: Nat Rev Cancer – volume: 22 start-page: 6068 year: 2003 end-page: 6077 article-title: Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses publication-title: EMBO J – volume: 24 start-page: 7669 year: 2004 end-page: 7680 article-title: Inhibition of HDM2 and activation of p53 by ribosomal protein L23 publication-title: Mol Cell Biol – volume: 279 start-page: 44475 year: 2004 end-page: 44482 article-title: Inhibition of MDM2‐mediated p53 ubiquitination and degradation by ribosomal protein L5 publication-title: J Biol Chem – volume: 5 start-page: 465 year: 2004 end-page: 475 article-title: Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2‐mediated degradation publication-title: Cancer Cell – volume: 149 start-page: 1269 year: 2012 end-page: 1283 article-title: Tumor suppression in the absence of p53‐mediated cell‐cycle arrest, apoptosis, and senescence publication-title: Cell – volume: 286 start-page: 7139 year: 2011 end-page: 7148 article-title: hALP, a novel transcriptional U three protein (t‐UTP), activates RNA polymerase I transcription by binding and acetylating the upstream binding factor (UBF) publication-title: J Biol Chem – volume: 9 start-page: 331 year: 2007 end-page: 338 article-title: Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2 publication-title: Nat Cell Biol – volume: 3 start-page: 577 year: 2003 end-page: 587 article-title: Regulation of HDM2 activity by the ribosomal protein L11 publication-title: Cancer Cell – volume: 378 start-page: 206 year: 1995 end-page: 208 article-title: Rescue of embryonic lethality in Mdm2‐deficient mice by absence of p53 publication-title: Nature – volume: 92 start-page: 725 year: 1998 end-page: 734 article-title: ARF promotes MDM2 degradation and stabilizes p53: ARF‐INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways publication-title: Cell – volume: 96 start-page: 11364 year: 1999 end-page: 11369 article-title: RING fingers mediate ubiquitin‐conjugating enzyme (E2)‐dependent ubiquitination publication-title: Proc Natl Acad Sci USA – volume: 125 start-page: 531 year: 2012 end-page: 537 article-title: HECT and RING finger families of E3 ubiquitin ligases at a glance publication-title: J Cell Sci – volume: 90 start-page: 595 year: 1997 end-page: 606 article-title: Activation of p53 sequence‐specific DNA binding by acetylation of the p53 C‐terminal domain publication-title: Cell – volume: 140 start-page: 384 year: 2010 end-page: 396 article-title: USP10 regulates p53 localization and stability by deubiquitinating p53 publication-title: Cell – volume: 107 start-page: 137 year: 2001 end-page: 148 article-title: Negative control of p53 by Sir2alpha promotes cell survival under stress publication-title: Cell – volume: 19 start-page: 1473 year: 2000 end-page: 1476 article-title: Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase publication-title: Oncogene – volume: 24 start-page: 7654 year: 2004 end-page: 7668 article-title: Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition publication-title: Mol Cell Biol – volume: 21 start-page: 301 year: 2014 end-page: 307 article-title: New insights into ubiquitin E3 ligase mechanism publication-title: Nat Struct Mol Biol – volume: 110 start-page: 3895 year: 2013 end-page: 3900 article-title: MOZ increases p53 acetylation and premature senescence through its complex formation with PML publication-title: Proc Natl Acad Sci USA – volume: 102 start-page: 10188 year: 2005 end-page: 10193 article-title: The C‐terminal lysines fine‐tune P53 stress responses in a mouse model but are not required for stability control or transactivation publication-title: Proc Natl Acad Sci USA – volume: 1 start-page: 769 year: 1995 end-page: 773 article-title: p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma publication-title: Clin Cancer Res – volume: 11 start-page: 1974 year: 1997 end-page: 1986 article-title: Repression of p53‐mediated transcription by MDM2: a dual mechanism publication-title: Genes Dev – volume: 75 start-page: 817 year: 1993 end-page: 825 article-title: WAF1, a potential mediator of p53 tumor suppression publication-title: Cell – volume: 137 start-page: 413 year: 2009 end-page: 431 article-title: Blinded by the light: the growing complexity of p53 publication-title: Cell – volume: 9 start-page: 402 year: 2008 end-page: 412 article-title: Transcriptional control of human p53‐regulated genes publication-title: Nat Rev Mol Cell Biol – volume: 23 start-page: 8902 year: 2003 end-page: 8912 article-title: Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53‐dependent ribosomal‐stress checkpoint pathway publication-title: Mol Cell Biol |
SSID | ssj0005978 |
Score | 2.5303867 |
Snippet | As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress... |
SourceID | pubmedcentral proquest pubmed wiley springer istex |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 349 |
SubjectTerms | Acetylation Active Transport, Cell Nucleus Apoptosis Cell cycle Cell Nucleus - metabolism Colorectal cancer Colorectal Neoplasms - metabolism Deoxyribonucleic acid DNA DNA Damage E3 ligase EMBO31 EMBO37 Genomes HCT116 Cells HEK293 Cells Humans Mdm2 N-Terminal Acetyltransferase E - genetics N-Terminal Acetyltransferase E - metabolism N-Terminal Acetyltransferases NAT10 p53 Protein Binding Protein Stability Proteolysis Proto-Oncogene Proteins c-mdm2 - metabolism Tumor Suppressor Protein p53 - metabolism Ubiquitination |
SummonAdditionalLinks | – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swELcQE9Ne0Ab7yMYmI02T9hAtdhw7eWQTHQK1mlgZaC-WnVxGhQjQDwn-e-7iNFu18bK3NHd1Ld_Z_Z19_h1j732d1WWii9gpqGNVgYsxsi0QyAnnS5V7X9N-x3CkD07U4Vm2zCakuzCBH6LfcKOZ0a7XNMGdny0r9hBrKFx6IvQUhDmIxfQRXbClrD6pvv3O8ijaxRglRSylOOvYfaiJT6sNIDqlgb39F9T8O2OyPzZdBbXtv9LgKdvs4CTfC_Z_xtag2WIbocDk3RZ7POyOzrfZj9HeWCR8GmrPw4xfZymnWw1hT5Z3BXvwFczvKEGu-RVU5vxIyIS7puILP7lZTFAUxMPqUj5nJ4P98ZeDuCuqEE8Q3GSxkAaEc4aO42QKmSkEeJPjMldqRBu5oZBKlYUrkgpUKTEgq1WdGNCQgjKQvmDrzVUDrxj3PqkzjTM4Sb2SUHm0uXZlmae-lM7oiH1oR9ReB-IM66YXlEdmMns6-mrl6Wjw3fwc2yxiO8sht90UmlmBgVBBVER5xHZ7MTo_nWi4Bq4WpGMQg2AIijovg4X6H5M6p-g3jZhZsV2vQMTaq5Jmct4SbCsKOaj_H5dW_qNbGDSR91jyHtt7T8TS1g361h_Qs_vDz8f9p9f_9a037Ak-65AJt8PW59MFvEVoNPfvWue_B99eA7w priority: 102 providerName: Wiley-Blackwell |
Title | NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2 |
URI | https://api.istex.fr/ark:/67375/WNG-2WNFS7ZT-5/fulltext.pdf https://link.springer.com/article/10.15252/embr.201540505 https://onlinelibrary.wiley.com/doi/abs/10.15252%2Fembr.201540505 https://www.ncbi.nlm.nih.gov/pubmed/26882543 https://www.proquest.com/docview/1768907818 https://www.proquest.com/docview/1770221568 https://pubmed.ncbi.nlm.nih.gov/PMC4772976 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdgCLQXxMZX2KiMhJB4iIi_k8dRrUygFgQdq3ix7MSBalo2ulZi__3u4iys2njgLcmdbMt3dn7nO98R8trXqi4zXaROhjqVVXApWLYFADnmfClz72s87xhP9MGh_DhTsy5JEt6Fue6_V1zxd-HEY9pOhsgCc5XeU0wYrNEw1MO_sRxFu-XCqi9Sztmsy-FzSwOAQXH6_twGKG_GRfbO0XXo2v57Ro_Iww400r0o5S1yJzTb5H4sI3mxTR6MOwf5Y_J9sjdlGV3ECvPhnJ4pQfHuQjx5pV1ZHvgUlhcYBtf8jCxL-onxjLqmois__72aAymSx9UJf0IOR_vT4UHalU5I5wBhVMq4Ccw5g043LoIyBQve5LCZlRowRW7QcJJl4YqsCrLkYHbVss5M0EEEaYJ4Sjaa0yY8J9T7rFYa1mkmvOSh8iBZ7coyF77kzuiEvGln1J7F9BjWLY4xWswoezT5YPnRZPTN_JhalZDdqym33UI5twzMnQITDuUJedWTQcXRb-GacLpCHgNIAwxN4HkWJdR3xnWONq5IiFmTXc-A6bPXKc38V5tGW6JhgeN_eyXla8MC0wi1x6L22F57EiJaNehb_wef3R-__9q_vfiPHnbIJjzrGOW2SzaWi1V4CbBn6QfkLpdfBq3iD_As8fMlbS75_g |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrXhcEJRXoECQAIlDROL4kRw4LNBlu9vkQLd0xcXYiQMr1LTsQ7A_h3_KOC9YUQ4ceow9cizPjD2fZzwD8FQXrMh8HnuKmsKjuVEeItsYDblA6YxGWhf2viNJ-fCIjqZsugU_27cwVbR765KsduqmRg95aU60TeAZWBvDb-Mox2b9HVHa4tX-W2TpM0IGe5M3Q68pJODN8EBnXkCECZQS1gVFQsNEHBgtIlTtjOMJGwkLI2gWq9jPDc0IgpCCFr4w3ISGChPiuJdgO2I8Yj3Y7vdHh6PfcSRxtd3jjhN7hATTJn_QOVNG-9ey7sd5xuzfMZmdY3bTbK7OvcENuN4YrG6_lrCbsGXKHbhcl7Bc78CVpHHO34IPaX8S-O68rm5vFu4ZC137bqK-9XWbkkDYZJZrG4JXfq5Jlu44IL6rytxd6dm31Qy76u4kPyG34ehCVvsO9MrT0twDV2u_YBz3CD_UlJhco1RxlWVRqDOiBHfgebWi8qxOzSHV_KuNVBNMHqfvJDlOB4fi40QyB3bbJZeNki5kgFArtsmOIgeedN2oXtZnokpzurI0Aq0cBLlIc7fmUPczwiOLr0MHxAbvOgKbunuzp5x9qVJ4Uwtq7PxftFz-Y1oIy6z0SCs9spMeB8JKDLrR_0En95LX77uv-__xh8dwdThJDuTBfjp-ANewndfRdrvQW85X5iGaX0v9qFEAFz5dtM79ApKHOPo |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-NISZeEIx_gQFGAiQeoiWOYycPPIxuZaO0QtCxihdjJw5UaFlpU0E_FN-Rc5wEKsYDD3uMfXIs3519P9_5DuCJLuIiC3jqK2YKn-VG-YhsUzTkQqUzlmhd2PuO4YgfHrPXk3iyAT_btzB1tHvrknRvGmyWprLaneVFW6-H7ppTbZN5htbeCNqYyoFZfUfEtnhxtI_sfUpp_2DcO_SbogL-FA_32A-pMKFSwrqjaGRikYZGiwTVPON42ibCQgqWpSoNcsMyioCkYEUgDDeRYcJEOO4luIywKLRYr8d7vyNK0nrjx70n9SkNJ00moXMmjJawZeKP88zav6MzOxftugFdn4D963CtMV3JnpO1G7Bhym244opZrrZha9i46W_Ch9HeOAzI3NW5NwsyiyNiX1C4-1_SFAfCJlOtbDBe-dmRVGQQ0oCoMidLPf22nGKX6x7mp_QWHF_IWt-GzfKsNHeBaB0UMcfdIog0oybXKF9cZVkS6YwqwT14Vq-onLkkHVLNv9qYNRHLk9ErSU9G_ffi41jGHuy0Sy4bdV3IEEFXatMeJR487rpR0az3RJXmbGlpBNo7CHeR5o7jUPczyhOLtCMPxBrvOgKbxHu9p5x-qZN5Mwtv7Pyft1z-Y1oI0Kz0SCs9spMeD6JaDLrR_0EnD4Yv33Vf9_7jD49g6-1-X745Gg3uw1Vs5i7sbgc2q_nSPEA7rNIPa-kn8Omi1e0XYK471A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=NAT10+regulates+p53+activation+through+acetylating+p53+at+K120+and+ubiquitinating+Mdm2&rft.jtitle=EMBO+reports&rft.au=Liu%2C+Xiaofeng&rft.au=Tan%2C+Yuqin&rft.au=Zhang%2C+Chunfeng&rft.au=Zhang%2C+Ying&rft.date=2016-03-01&rft.pub=Nature+Publishing+Group+UK&rft.issn=1469-221X&rft.eissn=1469-3178&rft.volume=17&rft.issue=3&rft.spage=349&rft.epage=366&rft_id=info:doi/10.15252%2Fembr.201540505&rft.externalDocID=10_15252_embr_201540505 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1469-221X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1469-221X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1469-221X&client=summon |